| Interpreting the significance of changes in health-related quality-of-life scores. D Osoba, G Rodrigues, J Myles, B Zee, J Pater Journal of clinical oncology 16 (1), 139-144, 1998 | 3170 | 1998 |
| Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial DA Palma, R Olson, S Harrow, S Gaede, AV Louie, C Haasbeek, L Mulroy, ... The Lancet 393 (10185), 2051-2058, 2019 | 1689 | 2019 |
| Clinically localized prostate cancer: AUA/ASTRO/SUO guideline. Part I: risk stratification, shared decision making, and care options MG Sanda, JA Cadeddu, E Kirkby, RC Chen, T Crispino, J Fontanarosa, ... The Journal of urology 199 (3), 683-690, 2018 | 1154* | 2018 |
| Stereotactic ablative radiotherapy for the comprehensive treatment of oligometastatic cancers: long-term results of the SABR-COMET phase II randomized trial DA Palma, R Olson, S Harrow, S Gaede, AV Louie, C Haasbeek, L Mulroy, ... Journal of Clinical Oncology 38 (25), 2830-2838, 2020 | 935 | 2020 |
| Predicting radiation pneumonitis after chemoradiation therapy for lung cancer: an international individual patient data meta-analysis DA Palma, S Senan, K Tsujino, RB Barriger, R Rengan, M Moreno, ... International Journal of Radiation Oncology* Biology* Physics 85 (2), 444-450, 2013 | 719 | 2013 |
| Height Above the Nearest Drainage–a hydrologically relevant new terrain model AD Nobre, LA Cuartas, M Hodnett, CD Rennó, G Rodrigues, A Silveira, ... Journal of Hydrology 404 (1-2), 13-29, 2011 | 676 | 2011 |
| Prediction of radiation pneumonitis by dose–volume histogram parameters in lung cancer—a systematic review G Rodrigues, M Lock, D D'Souza, E Yu, J Van Dyk Radiotherapy and oncology 71 (2), 127-138, 2004 | 543 | 2004 |
| Intensity-modulated fractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): acute toxicity findings from an international, randomised … DH Brand, AC Tree, P Ostler, H van der Voet, A Loblaw, W Chu, D Ford, ... The Lancet Oncology 20 (11), 1531-1543, 2019 | 462 | 2019 |
| An individual patient data metaanalysis of outcomes and prognostic factors after treatment of oligometastatic non–small-cell lung cancer AB Ashworth, S Senan, DA Palma, M Riquet, YC Ahn, U Ricardi, ... Clinical lung cancer 15 (5), 346-355, 2014 | 457 | 2014 |
| Stereotactic body radiation therapy for early-stage non-small cell lung cancer: Executive Summary of an ASTRO Evidence-Based Guideline GMM Videtic, J Donington, M Giuliani, J Heinzerling, TZ Karas, CR Kelsey, ... Practical radiation oncology 7 (5), 295-301, 2017 | 442 | 2017 |
| Stage I–II non-small-cell lung cancer treated using either stereotactic ablative radiotherapy (SABR) or lobectomy by video-assisted thoracoscopic surgery (VATS): outcomes of a … NE Verstegen, JWA Oosterhuis, DA Palma, G Rodrigues, FJ Lagerwaard, ... Annals of oncology 24 (6), 1543-1548, 2013 | 326 | 2013 |
| Is there an oligometastatic state in non-small cell lung cancer? A systematic review of the literature A Ashworth, G Rodrigues, G Boldt, D Palma Lung cancer 82 (2), 197-203, 2013 | 314 | 2013 |
| Clinically localized prostate cancer: AUA/ASTRO guideline, part I: introduction, risk assessment, staging, and risk-based management JA Eastham, GB Auffenberg, DA Barocas, R Chou, T Crispino, JW Davis, ... The Journal of urology 208 (1), 10-18, 2022 | 259 | 2022 |
| Practice recommendations for lung cancer radiotherapy during the COVID-19 pandemic: An ESTRO-ASTRO consensus statement M Guckenberger, C Belka, A Bezjak, J Bradley, ME Daly, D DeRuysscher, ... Radiotherapy and Oncology 146, 223-229, 2020 | 257 | 2020 |
| Radiographic changes after lung stereotactic ablative radiotherapy (SABR)–can we distinguish recurrence from fibrosis? A systematic review of the literature K Huang, M Dahele, S Senan, M Guckenberger, GB Rodrigues, A Ward, ... Radiotherapy and Oncology 102 (3), 335-342, 2012 | 245 | 2012 |
| Prostate volume contouring: a 3D analysis of segmentation using 3DTRUS, CT, and MR WL Smith, C Lewis, G Bauman, G Rodrigues, D D’Souza, R Ash, D Ho, ... International Journal of Radiation Oncology* Biology* Physics 67 (4), 1238-1247, 2007 | 232 | 2007 |
| Curative treatment of Stage I non-small-cell lung cancer in patients with severe COPD: stereotactic radiotherapy outcomes and systematic review D Palma, F Lagerwaard, G Rodrigues, C Haasbeek, S Senan International Journal of Radiation Oncology* Biology* Physics 82 (3), 1149-1156, 2012 | 230 | 2012 |
| Palliative thoracic radiotherapy in lung cancer: An American Society for Radiation Oncology evidence-based clinical practice guideline G Rodrigues, GMM Videtic, R Sur, A Bezjak, J Bradley, CA Hahn, ... Practical radiation oncology 1 (2), 60-71, 2011 | 218 | 2011 |
| Stereotactic ablative radiotherapy for the comprehensive treatment of 4–10 oligometastatic tumors (SABR-COMET-10): study protocol for a randomized phase III trial DA Palma, R Olson, S Harrow, RJM Correa, F Schneiders, CJA Haasbeek, ... BMC cancer 19, 1-15, 2019 | 211 | 2019 |
| Pre-treatment risk stratification of prostate cancer patients: A critical review G Rodrigues, P Warde, T Pickles, J Crook, M Brundage, L Souhami, ... Canadian Urological Association Journal 6 (2), 121, 2012 | 202 | 2012 |
David PalmaWestern UniversityVerified email at lhsc.on.ca
